Cancer Intervention China Pharmaceutical and Healthcare Analysis Information 2022

Pune, India, 29th January 2018: WiseGuyReports announced addition of new report, titled “The Chinese Market for Cancer Intervention”.

Pune, India – January 29, 2018 /MarketersMedia/ —

Report Scope:
The scope of the report includes cancer intervention applications, industries, markets, and companies in China. The markets for cancer intervention are given for the years 2016, 2017 and 2022.

The Chinese cancer intervention market includes two major segments: cancer treatment and cancer diagnosis and detection. Each major segment will be further divided and discussed by technology, drug type, end user, etc.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2820088-the-chinese-market-for-cancer-intervention

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities), and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai and others.

Key Players
ACCURAGEN
ACCURAY
ANNOROAD GENE TECHNOLOGY
ASTELLAS
ASTRAZENECA
BAYER CHINA LTD.
BEIJING GENETRON HEALTH CO. LTD.
BEIJING GENOMICS INSTITUTE
BEIJING IPE CENTER
BEIJING SANVALLEY TECHNOLOGY CO. LTD.
BEIJING SCIECURE PHARMACEUTICAL CO. LTD.
BEIJING SINOMDGENE TECHNOLOGY CO. LTD.
BEIJING SOLOMENBROTHERS MEDICAL TECHNOLOGY CO. LTD.
BRISTOL-MYERS SQUIBB (CHINA) INVESTMENT CO. LTD.
CHANGBAISHAN PHARMACEUTICAL CO. LTD. (CHANGBAISHAN)
CHIATAI TIANQING PHARMACEUTICAL GROUP CO. LTD.
CSPC PHARMACEUTICAL GROUP LTD.
ELEKTA INSTRUMENT AB STOCKHOLM
FSENS
GUANGZHOU AIC BIOTECHNOLOGIES LTD
GUANGZHOU ANCHORDX LLC
GUANGZHOU EZLIFE BIO INC.
GUANGZHOU FOREVER GEN BIO-TECHNOLOGY LTD.
GUIZHOU YIBAI PHARMACEUTICAL CO. LTD. (YIBAI)
GUODA DRUGSTORE
HAINAN ZHONGHE PHARMACEUTICAL CO. LTD.
HANSOH
HITACHI MEDICAL
HUADONG MEDICINE CO. LTD.
HUAPONT LIFE SCIENCES CO. LTD.
HYBIO PHARMACEUTICAL CO. LTD.
JIANGSU HENGRUI MEDICINE CO. LTD. (HENGRUI)
LIVZON PHARMACEUTICAL GROUP CO. LTD. (LIVZON)
LUNAN PHARMACEUTICAL GROUP
LUYE PHARMA GROUP (LUYE)
MASEP INFINI MEDICAL SCIENCE TECHNOLOGY CO. LTD.
MSD CHINA
NOVARTIS
PFIZER CHINA
QILU PHARMACEUTICAL CO. LTD.
ROCHE CHINA
SANOFI
SCICLONE PHARMACEUTICALS INC.
SHANGHAI BIOASIA GENE CO. LTD.
SHENZHEN HAPLOX BIOTECHNOLOGY CO. LTD.
SHENZHEN YUCEBIO CO. LTD.
SINOPHARM A-THINK PHARMACEUTICAL CO. LTD. (A-THINK)
SINOPHARM CHUANKANG PHARMACEUTICAL CO. LTD. (CHUANKANG)
SL PHARM
TAIHO PHARMA
VARIAN MEDICAL SYSTEMS INC.
WUHAN HUALONG BIO-CHEMICAL PHARMACEUTICAL CO. LTD.
YATAI PHARMACEUTICALS
ZHEJIANG JIUXU PHARMACEUTICAL CO. LTD. (JIUXU)
ZHEJIANG KANGLAITE PHARMACEUTICAL CO. LTD. (KANGLAITE)
ZHENDONG GROUP

Report Includes:
– An overview of the Chinese market for cancer intervention.
– Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
– Coverage of current procedures as well as those expected to be realized over the next five years.
– Analysis of the market’s dynamics, specifically growth drivers, restraints, and opportunities
– Profiles of major players in the industry.

Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Largest Segments in the Chinese Cancer Intervention Market
Fastest Growing Segments in the Chinese Cancer Intervention Market
Chapter 3 Market and Technology Background
Market Background
Number of Cancer Cases in China
Geographical Distribution
Medical System
Drug Distribution System in China
Drug Makers
Foreign Drug Makers
Government Relationship
First- and Second-Tier Cities
Sales Channels
Homegrown Drug Makers
Government Relationship
Third- and Fourth-Tier Cities
Sales Channels
Drug Retailers
Exclusive Distributors
Hospitals
Retailers
End Consumers
Key Trends in the Chinese Cancer Intervention Market
Technology Background
Key Technology Trends in the Chinese Cancer Intervention Market
Chapter 4 Market Breakdown by Technology Type
Antitumor Drugs
Immunopotentiators
Immunosuppressors
Adjuvant Drugs
Cancer Surgery
Radiotherapy
Diagnosis and Detection
Chapter 5 Market Breakdown by Product
Chapter 6 Market Breakdown by End Use
Chinese Lung Cancer Intervention Market
Chapter 7 Market Breakdown by Region
Chapter 8 Analysis of Market Opportunities
Chapter 9 Company Profiles
Chapter 10 Appendix: Glossary
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820088-the-chinese-market-for-cancer-intervention

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/cancer-intervention-china-pharmaceutical-and-healthcare-analysis-information-2022/293208

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 293208